Global Medtech Guidance Tracker: April 2021
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Thirty-two guidance documents have been posted on the tracker since its last update.
You may also be interested in...
Singapore drives much of the medtech regulatory and policy thought leadership in the ASEAN region, as shown in its regulatory collaboration with Thailand and actions on cybersecurity and packaging waste.
In some cases, a “substantial” change to a clinical investigation will mean having to start anew. Industry is in urgent need of clarification of the term. But does latest EU guidance help sufficiently?
COVID-19 is driving changes to how clinical trials are being conducted in the US, with 44% of respondents who participated in a recent survey saying they have adapted or plan to become decentralized in coming months.